|Bazedoxifene||Selective estrogen receptor modulator|
|Trade names||Duavee, Duavive|
|Main uses||Symptoms of menopause, osteoporosis after menopause|
|Side effects||Muscle spasms, nausea, diarrhea, heart burn, dizziness, pain|
|US NLM||Bazedoxifene/conjugated estrogens|
Bazedoxifene/conjugated estrogens, sold under the brand name Duavee and Duavive, is a combination medication used to treat symptoms of menopause and osteoporosis after menopause. It is taken by mouth. It should be used short term.
Common side effects include muscle spasms, nausea, diarrhea, heart burn, dizziness, and pain. Other side effects may include blood clots, stroke, and endometrial cancer. It should not be used in pregnancy. It contains bazedoxifene, a selective estrogen receptor modulator, and conjugated estrogens.
It is taken as one tablet of 0.45 mg conjugated estrogens and 20 mg bazedoxifene a day.
Society and culture
- "Selective Estrogen Receptor Modulators". LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases. 2012. Archived from the original on 11 January 2022. Retrieved 8 January 2022.
- "Bazedoxifene / conjugated estrogens (Duavee) Use During Pregnancy". Drugs.com. 16 February 2019. Archived from the original on 26 June 2020. Retrieved 23 June 2020.
- "DailyMed - DUAVEE- conjugated estrogens/bazedoxifene tablet, film coated". dailymed.nlm.nih.gov. Archived from the original on 10 May 2021. Retrieved 8 January 2022.
- "Bazedoxifene Monograph for Professionals". Drugs.com. Archived from the original on 19 April 2021. Retrieved 8 January 2022.
- "Duavive EPAR". European Medicines Agency (EMA). Archived from the original on 2020-06-10. Retrieved 2020-06-10.
- "Conjugated Estrogens and Bazedoxifene Prices, Coupons & Savings Tips - GoodRx". GoodRx. Archived from the original on 16 April 2016. Retrieved 8 January 2022.
- "Pfizer recalls 2 batches of Duavive". Zenopa. Archived from the original on 2020-09-27.